Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.
Shi Q, Qi X, Tang P, Fan L, Chen L, Wang S, Liang Y, Hu Y, Wang M, Ren L, Zhang G, Tan X, Yuan L, Du J, Wu X, Wang M, Che H, Lv P, Chen D, Hu J, Li Q, Zhang Y, Yang K, Zhong Y, Chen C, Zhou Z, Qian L, Zhang J, Ma M, Sun Y, Zhang Y, Jiang J. Shi Q, et al. MedComm (2020). 2023 Dec 7;4(6):e435. doi: 10.1002/mco2.435. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38077249 Free PMC article.
Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial.
Liang Y, Liu J, Ge J, Shi Q, Zhang G, Wan A, Luo T, Tian H, Fan L, Wang S, Chen L, Tang P, Zhu K, Jiang J, Bian X, Zhang Y, Qi X. Liang Y, et al. Among authors: shi q. EClinicalMedicine. 2024 Apr 11;71:102585. doi: 10.1016/j.eclinm.2024.102585. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38638401 Free PMC article.
7,927 results